medigraphic.com
ISSN 0210-5187 (Electronic)

2009, Number 2

<< Back Next >>

Med Cutan Iber Lat Am 2009; 37 (2)

Facial chronic granumatous disease - a case report

Oyama Okajima, RM; D'Apparecida Santos Machado Filho, C; Pedreira Paixão, M; Mendonça de Barros, MI; Chmeliauskas Moya, M; Simões e Silva Enokihara, MM

Language: Portugués
References: 12
Page: 90-93
PDF size: 204.11 Kb.


Text Extraction

Facial chronic granulomatous disease or lupus miliaris disseminatus faciei is a granulomatous disorder of unknown aetiopathology. It is characterized by red-brown or yellow papules, nodules or pustules in the central areas of the face leaving small pitted scars. Histopathologic findings include epithelioid cell granuloma with central necrosis surrounded by a mononuclear infiltrate. We describe the case of a young man who had facial chronic granulomatous disease treated with prednisone and doxycycline.


REFERENCES

  1. Scheuer MRV, Waal RIFV, Starink TM. Lupus miliaris disseminatus faciei: a distinctive rosácea-like syndrome and not granulomatous form of rosacea. Dermatology 2003; 206:120-3.

  2. Uesugi Y, Aiba S, Usuba M, Tagami H. Oral prednisone in treatment of acne agminata. Br J Dermatol 1996;134:1098-100.

  3. Darouti M, Zaher H. Lupus miliaris disseminatus faciei – pathology study of early, fully developed and late lesions. Int J Dermatol 1993;32: 508-11.

  4. Bedlow AJ, Otter M, Marsden RA. Axillary acne agminata (lupus miliar disseminatus faciei). Cl Exp Dermatol 1998;23:125-8.

  5. Skowron F, Causeret AS, Pabion C, Viallard AM, Balme B, Thomas L. F.I.G.U.R.E.: Facial Idiopathic GranUlomas with Regressive Evolution. Dermatology 2000;201:287-9.

  6. Hodak E, Atrattner A, Feuerman H, Feinmesser M, David M. Lupus miliaris disseminatus faciei – the DNA of Mycobacterium tuberculosis is not detectable in active lesions by polymerase chain reaction. Br J Dermatol 1997;137:614-9.

  7. Farrar CW, Bell HK, Dobson CM, Sharpe GR. Facial and axillary acne agminata. Br J Dermatol 2003;149:1076.

  8. Ferrara G, Cannone M, Scalvenzi M, Delfino M, Staibano S, Rosa G, Barberis M. Facial granulomatous disease. Am J Dermatotopathol 2001;23:8-15.

  9. Abulafia LA, Azulay D, Azulay R. In Azulay R, Azulay D. Dermatologia. 3.ed. Rio de Janeiro, Guanabara Koogan, 2004, pp. 156-161.

  10. Moloney FJ, Egan CA. Clinicopathological cases. Cl Exp Dermatol 2003;28:685-6.

  11. Weinberg JM. The anti-inflammatory effects of tetracyclines. Cutis 2005;75:6-11.

  12. Melo FAF, Hijjar MA. I Consenso Brasileiro de Tuberculose. J Pneumol 1997;23:281-342.




2020     |     www.medigraphic.com